GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: G0775 is an optimized arylomycin derivative with promising in vitro antibacterial activity against multidrug-resistant (MDR) Gram-negative bacteria [1].
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
| G0775 is an inhibitor of bacterial type I signal peptidase, an essential inner membrane enzyme and an integral part of the protein export pathway [1-2]. |